18.06.2015 Views

Web-economic-crisis-health-systems-and-health-web

Web-economic-crisis-health-systems-and-health-web

Web-economic-crisis-health-systems-and-health-web

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Turkey<br />

Salih Mollahaliloglu <strong>and</strong> Mehtap Tatar<br />

Economic trends<br />

• Real per capita GDP in Turkey declined in 2009 by 4.0%, although<br />

growth surpassed pre-<strong>crisis</strong> levels the following year. The budget deficit in<br />

2009 increased to 7% of GDP, as the government share of GDP increased.<br />

• The unemployment rate increased in 2009, but has since returned to<br />

European mean levels.<br />

• Health spending as a share of government expenditure remained stable<br />

between 2008 <strong>and</strong> 2011. Although OOP expenditure per capita decreased<br />

slightly in 2009 by 1.8%, public expenditure per capita increased<br />

throughout the 2008 to 2011 period (Turkey: Figs 1 <strong>and</strong> 2).<br />

Policy responses<br />

Changes to public funding for the <strong>health</strong> system<br />

• The budget of the Ministry of Health increased between 2008 <strong>and</strong> 2011.<br />

• Payment of SHI contributions for government employees <strong>and</strong> their dependants<br />

was transferred from the Ministry of Finance to the Social Security Institution<br />

(2010); expenditure for Green Card holders was transferred from the Ministry<br />

of Health to the Social Security Institution (2012).<br />

Population (entitlement)<br />

• No response reported.<br />

The benefits package<br />

• No response reported.<br />

User charges<br />

• Reimbursement rate for br<strong>and</strong>ed drugs without a generic option increased<br />

(from 32.5% to 41% of the ex-factory price) (2011).<br />

• Reduction of the reimbursement rate for drugs in the reference price system<br />

from 15% to 10% of the price of the cheapest drug (2011).<br />

• Reduction of the reimbursement rate for br<strong>and</strong>ed drugs with a generic option<br />

(from 28% to 20.5%) <strong>and</strong> for generics (from 28% to 20.5%) (2011).<br />

• Introduction of a new co-payment for prescriptions (TL 3 for up to three items<br />

<strong>and</strong> TL 1 for each additional item) (2012).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!